Literature DB >> 18465109

Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington's disease.

A W Michell1, A O G Goodman, A H D Silva, S E Lazic, A J Morton, R A Barker.   

Abstract

Huntington's disease (HD) is a severe neurodegenerative condition in which the impairment in voluntary movement is related to functional disability. Clinical assessment of motor deficit currently relies largely on subjective rating scales without objective measurement. We have developed a quick and easy-to-use hand tapping device that enables measurement of (a) the number of taps in 30 seconds, (b) variability in tapping rhythm and (c) fatigue over the testing period. Initial cross-sectional testing of 178 consecutive HD clinic patients using an early model of the device showed that the total number of taps in 30 seconds correlated with the motor UHDRS (Spearmann's rho, r(s) = -0.81, p < 0.0001) and independence scores (r(s) = 0.78, p = 0.01). Longitudinal data from a small cohort followed over 10 years reveals a correlation between total number of taps in 30 seconds and motor UHDRS over time (rs = -0.49, p < 0.001), and suggests the technique may provide an objective measure of disease progression. Further tests on 15 HD patients and 9 controls were repeated three times in a single day using an updated device. The HD group made significantly fewer taps in 30 seconds (median HD = 79, control = 104, p = 0.009) and had greater variability of inter-tap interval (mean interdecile range HD = 148, control = 56, p = 0.016) compared to controls. Both the total number of taps and variability of inter-tap interval correlated with motor UHDRS. Of vital importance for any potential marker of disease progression is that these tapping parameters were reproducible with repeated measurement. Given that hand tapping parameters differ between HD and control populations, they correlate with motor UHDRS over time and are reproducible, we propose that assessment of hand tapping represents a useful objective adjunct to the clinical assessment of HD patients.

Entities:  

Mesh:

Year:  2008        PMID: 18465109     DOI: 10.1007/s00415-008-0859-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease.

Authors:  J P van Vugt; S Siesling; K K Piet; A H Zwinderman; H A Middelkoop; J J van Hilten; R A Roos
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

2.  Bradykinesia in early Huntington's disease.

Authors:  R Sánchez-Pernaute; G Künig; A del Barrio Alba; J G de Yébenes; P Vontobel; K L Leenders
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

3.  Retest effects and cognitive decline in longitudinal follow-up of patients with early HD.

Authors:  A C Bachoud-Lévi; P Maison; P Bartolomeo; M F Boissé; G Dalla Barba; A M Ergis; S Baudic; J D Degos; P Cesaro; M Peschanski
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

4.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

5.  Objective assessment of progression in Huntington's disease: a 3-year follow-up study.

Authors:  R Reilmann; F Kirsten; L Quinn; H Henningsen; K Marder; A M Gordon
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

6.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene.

Authors:  S C Kirkwood; E Siemers; C Bond; P M Conneally; J C Christian; T Foroud
Journal:  Arch Neurol       Date:  2000-07

8.  Assessment of simple movements reflects impairment in Huntington's disease.

Authors:  Carsten Saft; Jürgen Andrich; Nina-Marie Meisel; Horst Przuntek; Thomas Müller
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

Review 9.  The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.

Authors:  Jia Yi Li; Natalija Popovic; Patrik Brundin
Journal:  NeuroRx       Date:  2005-07

10.  The measurement of abnormal movement: methods developed for Huntington's disease.

Authors:  S E Folstein; B Jensen; R J Leigh; M F Folstein
Journal:  Neurobehav Toxicol Teratol       Date:  1983 Nov-Dec
View more
  14 in total

1.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

2.  Quantification of ethanol's antipunishment effect in humans using the generalized matching equation.

Authors:  Erin B Rasmussen; M Christopher Newland
Journal:  J Exp Anal Behav       Date:  2009-09       Impact factor: 2.468

3.  The structural correlates of functional deficits in early huntington's disease.

Authors:  Christine Delmaire; Eve M Dumas; Michael A Sharman; Simon J A van den Bogaard; Romain Valabregue; Céline Jauffret; Damian Justo; Ralf Reilmann; Julie C Stout; David Craufurd; Sarah J Tabrizi; Raymund A C Roos; Alexandra Durr; Stéphane Lehéricy
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

4.  [A biomechanical analysis of cyclical hand motor function: a pilot study in different Parkinsonian syndromes].

Authors:  T Wolfsegger; I Rotaru; R Topakian; R Pichler; M Sonnberger; F T Aichner; H Schwameder
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

5.  Self-paced timing detects and tracks change in prodromal Huntington disease.

Authors:  Kelly C Rowe; Jane S Paulsen; Douglas R Langbehn; Kevin Duff; Leigh J Beglinger; Chiachi Wang; Justin J F O'Rourke; Julie C Stout; David J Moser
Journal:  Neuropsychology       Date:  2010-07       Impact factor: 3.295

6.  Tapping linked to function and structure in premanifest and symptomatic Huntington disease.

Authors:  N Bechtel; R I Scahill; H D Rosas; T Acharya; S J A van den Bogaard; C Jauffret; M J Say; A Sturrock; H Johnson; C E Onorato; D H Salat; A Durr; B R Leavitt; R A C Roos; G B Landwehrmeyer; D R Langbehn; J C Stout; S J Tabrizi; R Reilmann
Journal:  Neurology       Date:  2010-11-10       Impact factor: 9.910

7.  A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.

Authors:  Florian Lipsmeier; Cedric Simillion; Atieh Bamdadian; Rosanna Tortelli; Lauren M Byrne; Yan-Ping Zhang; Detlef Wolf; Anne V Smith; Christian Czech; Christian Gossens; Patrick Weydt; Scott A Schobel; Filipe B Rodrigues; Edward J Wild; Michael Lindemann
Journal:  J Med Internet Res       Date:  2022-06-28       Impact factor: 7.076

8.  Tracking Huntington's Disease Progression Using Motor, Functional, Cognitive, and Imaging Markers.

Authors:  Pubu M Abeyasinghe; Jeffrey D Long; Adeel Razi; Dorian Pustina; Jane S Paulsen; Sarah J Tabrizi; Govinda R Poudel; Nellie Georgiou-Karistianis
Journal:  Mov Disord       Date:  2021-05-20       Impact factor: 9.698

9.  Visualising disease progression on multiple variables with vector plots and path plots.

Authors:  Stanley E Lazic; Sarah L Mason; Andrew W Michell; Roger A Barker
Journal:  BMC Med Res Methodol       Date:  2009-05-27       Impact factor: 4.615

10.  The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.

Authors:  Roger A Barker; Sarah L Mason; Timothy P Harrower; Rachel A Swain; Aileen K Ho; Barbara J Sahakian; Raj Mathur; Sohier Elneil; Steven Thornton; Carrie Hurrelbrink; Richard J Armstrong; Pam Tyers; Emma Smith; Adrian Carpenter; Paola Piccini; Yen F Tai; David J Brooks; Nicola Pavese; Colin Watts; John D Pickard; Anne E Rosser; Stephen B Dunnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-23       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.